Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H11N5O3 |
Molecular Weight | 225.2046 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2COCCO)C(=O)N1
InChI
InChIKey=MKUXAQIIEYXACX-UHFFFAOYSA-N
InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000175468
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-VATC |
QS01AD03
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
FDA ORPHAN DRUG |
313210
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
21.1
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
FDA ORPHAN DRUG |
513615
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.4.1
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-VATC |
QD06BB53
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000180187
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-ATC |
D06BB03
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-ATC |
D06BB53
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NCI_THESAURUS |
C1556
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-ATC |
J05AB01
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
FDA ORPHAN DRUG |
325010
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-VATC |
QD06BB03
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-VATC |
QJ05AB01
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
WHO-ATC |
S01AD03
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000020060
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
LIVERTOX |
NBK548548
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000180188
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NCI_THESAURUS |
C29575
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
FDA ORPHAN DRUG |
37589
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1012065
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
4829
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
DTXSID1022556
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
59277-89-3
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
758477
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
85
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
DB00787
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
645011
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
6511
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
100000092808
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
X4HES1O11F
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
ACICLOVIR
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
2453
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
CHEMBL184
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
Acyclovir
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
D000212
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
C205
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
X4HES1O11F
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
4435
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
261-685-1
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
m1404
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | Merck Index | ||
|
ACYCLOVIR
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | Description: White or almost white, crystalline powder. Solubility: Slightly soluble in water; freely soluble in dimethyl sulfoxide; very slightly soluble in ethanol (96%). It dissolves in dilute solutions of mineral acids and alkali hydroxides. Category: Antiviral (Purine nucleoside analogue). Storage: Preserve in well-closed containers. Protect from light and moisture. Additional information: Aciclovir may exhibit polymorphism. Definition: Aciclovir contains not less than 98.5% and not more than 101.0% of C8H11N5O3, calculated with reference to the dried substance. | ||
|
281
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | RxNorm | ||
|
135398513
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY | |||
|
SUB05235MIG
Created by
admin on Fri Dec 15 15:23:38 UTC 2023 , Edited by admin on Fri Dec 15 15:23:38 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE ACTIVE (PARENT)
PRODRUG (METABOLITE ACTIVE)
PRODRUG (METABOLITE ACTIVE)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)